Similarly, miR-450b-5p, suppressed in RMS by TGF-β1 through a pathway mediated by Smad3 and Smad4, exerted anti-tumour effects in tumour implants and cells by arresting RMS growth and upregulating MyoD expression [71]. This evidence concerns the gene MYOD1 and neoplasm.